Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myles C Cabot

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta|January 18, 2003
Glucosylceramide synthase and apoptosisRichard J Bleicher, Myles C Cabot
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Sphingolipid metabolism and drug resistance in hematological malignanciesValerie Gouaze-Andersson, Myles C Cabot
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosisYong-Yu Liu, Myles C Cabot
Biochimica Et Biophysica Acta|October 3, 2006
Glycosphingolipids and drug resistanceValerie Gouaze-Andersson, Myles C Cabot
Cancer Chemotherapy and Pharmacology|November 13, 2010
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cellsMaria C Messner, Myles C Cabot
Advances in Experimental Medicine and Biology|October 6, 2010
Glucosylceramide in humansMaria C Messner, Myles C Cabot
Biochimica Et Biophysica Acta|May 13, 2015
Tamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsSamy A F Morad, Myles C Cabot
Nature Reviews. Cancer|December 14, 2012
Ceramide-orchestrated signalling in cancer cellsSamy A F Morad, Myles C Cabot
Advances in Cancer Research|August 1, 2018
The Onus of Sphingolipid Enzymes in Cancer Drug ResistanceSamy A F Morad, Myles C Cabot
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Ceramide-based therapeutics for the treatment of cancerBrian M Barth, Myles C Cabot, Mark Kester
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|January 18, 2003
Glucosylceramide synthase and apoptosisRichard J Bleicher, Myles C Cabot
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Sphingolipid metabolism and drug resistance in hematological malignanciesValerie Gouaze-Andersson, Myles C Cabot
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosisYong-Yu Liu, Myles C Cabot
Biochimica Et Biophysica Acta|October 3, 2006
Glycosphingolipids and drug resistanceValerie Gouaze-Andersson, Myles C Cabot
Cancer Chemotherapy and Pharmacology|November 13, 2010
Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cellsMaria C Messner, Myles C Cabot
Advances in Experimental Medicine and Biology|October 6, 2010
Glucosylceramide in humansMaria C Messner, Myles C Cabot
Biochimica Et Biophysica Acta|May 13, 2015
Tamoxifen regulation of sphingolipid metabolism--Therapeutic implicationsSamy A F Morad, Myles C Cabot
Nature Reviews. Cancer|December 14, 2012
Ceramide-orchestrated signalling in cancer cellsSamy A F Morad, Myles C Cabot
Advances in Cancer Research|August 1, 2018
The Onus of Sphingolipid Enzymes in Cancer Drug ResistanceSamy A F Morad, Myles C Cabot
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Ceramide-based therapeutics for the treatment of cancerBrian M Barth, Myles C Cabot, Mark Kester
Pageof 7